Literature DB >> 30535065

Exploring the Relationship Between Patient Activation, Treatment Satisfaction, and Decisional Conflict in Patients Approaching End-Stage Renal Disease.

Miriam Vélez-Bermúdez1, Alan J Christensen1,2, Ellen M Kinner1, Anne I Roche1, Mony Fraer2.   

Abstract

BACKGROUND: Patients approaching end-stage renal disease (ESRD) experience a high level of decisional conflict because they are often not provided with sufficient support and information regarding different treatment options prior to renal failure. Decisional conflict is an important correlate of treatment satisfaction, as it is associated with disease- and treatment-related knowledge that can inform decision-making. Patient activation, the willingness and ability to independently manage one's own health and healthcare, is an individual difference factor that may have important mitigating effects on decisional conflict.
PURPOSE: To identify modifiable factors that may enhance the decision-making process in patients approaching ESRD by exploring potential mediational effects between decisional conflict, treatment satisfaction, and patient activation.
METHODS: Sixty-four patients approaching ESRD completed self-report measures (32% response rate). Measures included the Decisional Conflict Scale, the Kidney Disease Treatment Questionnaire, and the Patient Activation Measure Short Form.
RESULTS: There was a high level of self-reported decisional conflict in this sample. Linear regressions revealed main effects among treatment satisfaction, patient activation, and decisional conflict. These variables were entered into PROCESS to assess a mediational pattern. Results showed that higher chronic kidney disease-related treatment satisfaction predicted lower decisional conflict through higher patient activation in a statistical mediational relationship.
CONCLUSIONS: While the link between treatment satisfaction and decision-making is well established, these results suggest this relationship might be partially explained by patient activation, a potentially modifiable process in patients approaching ESRD. Therefore, interventions that encourage patients to become actively involved in their care could also reduce decisional conflict among patients approaching ESRD. © Society of Behavioral Medicine 2018. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Chronic kidney disease; Decisional conflict; Patient activation; Treatment decision-making; Treatment satisfaction

Year:  2019        PMID: 30535065      PMCID: PMC6937620          DOI: 10.1093/abm/kay091

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  38 in total

1.  Development and testing of a short form of the patient activation measure.

Authors:  Judith H Hibbard; Eldon R Mahoney; Jean Stockard; Martin Tusler
Journal:  Health Serv Res       Date:  2005-12       Impact factor: 3.402

2.  Conflict when making decisions about dialysis modality.

Authors:  Nien-Hsin Chen; Yu-Ping Lin; Shu-Yuan Liang; Heng-Hsin Tung; Shiow-Luan Tsay; Tsae-Jyy Wang
Journal:  J Clin Nurs       Date:  2017-07-17       Impact factor: 3.036

Review 3.  What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs.

Authors:  Judith H Hibbard; Jessica Greene
Journal:  Health Aff (Millwood)       Date:  2013-02       Impact factor: 6.301

4.  Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers.

Authors:  Judith H Hibbard; Jean Stockard; Eldon R Mahoney; Martin Tusler
Journal:  Health Serv Res       Date:  2004-08       Impact factor: 3.402

Review 5.  Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status.

Authors:  E A G Joosten; L DeFuentes-Merillas; G H de Weert; T Sensky; C P F van der Staak; C A J de Jong
Journal:  Psychother Psychosom       Date:  2008-04-16       Impact factor: 17.659

6.  Influence of a patient decision aid on decisional conflict related to PSA testing: a structural equation model.

Authors:  Robert L Stephens; Ye Xu; Robert J Volk; Lawrence E Scholl; Stephanie L Kamin; E Wayne Holden; Leonardo A Stroud
Journal:  Health Psychol       Date:  2008-11       Impact factor: 4.267

7.  Decisional conflict between treatment options among end-stage renal disease patients evaluated for kidney transplantation.

Authors:  Laura McPherson; Mohua Basu; Jennifer Gander; Stephen O Pastan; Sumit Mohan; Michael S Wolf; Mariana Chiles; Allison Russell; Kristie Lipford; Rachel E Patzer
Journal:  Clin Transplant       Date:  2017-05-29       Impact factor: 3.456

8.  Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: study protocol for a randomized controlled trial.

Authors:  Maarten Cuypers; Romy E D Lamers; Paul J M Kil; Lonneke V van de Poll-Franse; Marieke de Vries
Journal:  Trials       Date:  2015-05-27       Impact factor: 2.279

9.  Prevalence of clinically significant decisional conflict: an analysis of five studies on decision-making in primary care.

Authors:  Philippe Thompson-Leduc; Stéphane Turcotte; Michel Labrecque; France Légaré
Journal:  BMJ Open       Date:  2016-06-28       Impact factor: 2.692

Review 10.  Clarifying values: an updated review.

Authors:  Angela Fagerlin; Michael Pignone; Purva Abhyankar; Nananda Col; Deb Feldman-Stewart; Teresa Gavaruzzi; Jennifer Kryworuchko; Carrie A Levin; Arwen H Pieterse; Valerie Reyna; Anne Stiggelbout; Laura D Scherer; Celia Wills; Holly O Witteman
Journal:  BMC Med Inform Decis Mak       Date:  2013-11-29       Impact factor: 2.796

View more
  8 in total

1.  "I Wish Someone Had Told Me That Could Happen": A Thematic Analysis of Patients' Unexpected Experiences With End-Stage Kidney Disease Treatment.

Authors:  Nicole DePasquale; Ashley Cabacungan; Patti L Ephraim; LaPricia Lewis-Boyér; Clarissa J Diamantidis; Neil R Powe; L Ebony Boulware
Journal:  J Patient Exp       Date:  2019-09-03

Review 2.  Amplifying the Patient Voice: Key Priorities and Opportunities for Improved Transplant and Living Donor Advocacy and Outcomes During COVID-19 and Beyond.

Authors:  Amy D Waterman; Jim Gleason; Louise Lerminiaux; Emily H Wood; Alexander Berrios; Laurie A Meacham; Anne Osuji; Rachyl Pines; John D Peipert
Journal:  Curr Transplant Rep       Date:  2020-09-01

3.  Comparison of shared decision making in patients undergoing hemodialysis and peritoneal dialysis for choosing a dialysis modality.

Authors:  Sepide Ghodsian; Mansour Ghafourifard; Akram Ghahramanian
Journal:  BMC Nephrol       Date:  2021-02-23       Impact factor: 2.388

4.  Disparities in dialysis modality decision-making using a social-ecological lens: a qualitative approach.

Authors:  Miriam Vélez-Bermúdez; Jenna L Adamowicz; Natoshia M Askelson; Susan K Lutgendorf; Mony Fraer; Alan J Christensen
Journal:  BMC Nephrol       Date:  2022-08-05       Impact factor: 2.585

5.  Decisional Conflict About Kidney Failure Treatment Modalities Among Adults With Advanced CKD.

Authors:  Nicole DePasquale; Jamie A Green; Patti L Ephraim; Sarah Morton; Sarah B Peskoe; Clemontina A Davenport; Dinushika Mohottige; Lisa McElroy; Tara S Strigo; Felicia Hill-Briggs; Teri Browne; Jonathan Wilson; LaPricia Lewis-Boyer; Ashley N Cabacungan; L Ebony Boulware
Journal:  Kidney Med       Date:  2022-08-04

6.  Changes in patient activation in people starting dialysis: A prospective longitudinal, observational study.

Authors:  Wael F Hussein; Paul N Bennett; Anna Carrasco; Sumi Sun; Marc Reiterman; Emily Watson; Brigitte Schiller
Journal:  Hemodial Int       Date:  2022-04-19       Impact factor: 1.543

7.  Measuring Patient Activation as Part of Kidney Disease Policy: Are We There Yet?

Authors:  Devika Nair; Kerri L Cavanaugh
Journal:  J Am Soc Nephrol       Date:  2020-06-11       Impact factor: 10.121

8.  Factors promoting shared decision-making in renal replacement therapy for patients with end-stage kidney disease: systematic review and qualitative meta-synthesis.

Authors:  Yu Shi; Wang Li; Fangjian Duan; Shi Pu; Hongmei Peng; Mei Ha; Yu Luo
Journal:  Int Urol Nephrol       Date:  2021-06-22       Impact factor: 2.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.